Quote For Anesiva, Inc. ANSV.O
sector: Healthcare ·
industry: Biotechnology ·
As of
30 Nov 2009
0.12USD
$0.12
30 Nov 2009
+0.00%
$0.12
$0.13
285,059
$0.13
$0.12
$1.49
$0.07
2.08
882,341
News
Press Releases
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Kranda, Michael |
President, Chief Executive Officer, Director |
544,397 |
| Tran, John |
Vice President - Finance, Chief Accounting Officer |
-- |
| Janney, Daniel |
Director |
-- |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
$5.06 |
| Shares Outstanding (Mil.) |
40.47 |
| Float (Mil.) |
20.90 |
| |
| Dividend Information |
| Yield % |
-99,999.99 |
| Annual Dividend ($ USD) |
0.00 |
| Payout Ratio(TTM) % |
-- |
| |
| Financial Strength |
| Quick Ratio |
0.22 |
| Current Ratio |
0.08 |
| LT Debt/Equity |
-- |
| Total Debt/Equity |
-- |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
-- |
| Price/Sales(TTM) |
5,058.38 |
| Price/Book(TTM) |
-- |
| Price/Cash Flow(TTM) |
-- |
| |
|
| Per Share Data |
| Earnings(TTM) |
$-0.88 |
| Sales(TTM) |
$0.00 |
| Book Value(MRQ) |
$-0.46 |
| Cash Flow(TTM) |
$-0.85 |
| Cash(MRQ) |
$0.02 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
-234.52 |
| Return on Assets(TTM) |
-95.34 |
| Return on Investment(TTM) |
-182.18 |
| |
|
| Margins |
| Gross Margin(TTM) % |
-1,979,400.00 |
| Operating Margin(TTM) % |
-3,514,900.00 |
| Profit Margin(TTM) % |
-3,522,900.00 |
|
| |
|
UK
US
- Europe
- Asia
- UK Most Actives